MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41419-019-1893-6

Медицинская библиотека · Cell death & disease · 2019

Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway.

Ying Lei, Li Na, He Zhengyue, Zeng Xueqin, Nan Yan, Chen Jiantong, Miao Peipei, Ying Yunyun, Lin Wei, Zhao Xinyu, Lu Lu, Chen Mengke, Cen Wei, Guo Tonglin, Li Xiaokun, Huang Zhifeng, Wang Yang

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Endothelial dysfunction initiates and exacerbates hypertension, atherosclerosis and other cardiovascular complications in diabetic mellitus. FGF21 is a hormone that mediates a number of beneficial effects relevant to metabolic disorders and their associated complications. Nevertheless, it remains unclear as to whether FGF21 ameliorates endothelial dysfunction. Therefore, we investigated the effect of FGF21 on endothelial function in both type 1 and type 2 diabetes. We found that FGF21 reduced hyperglycemia and ameliorated insulin resistance in type 2 diabetic mice, an effect that was totally lost in type 1 diabetic mice. However, FGF21 activated AMPKα, suppressing oxidative stress and enhancing endothelium-dependent vasorelaxation of aorta in both types, suggesting a mechanism that is independent of its glucose-lowering and insulin-sensitizing effects. In vitro, we identified a direct action of FGF21 on endothelial cells of the aorta, in which it bounds to FGF receptors to alleviate impaired endothelial function challenged with high glucose. Furthermore, the CaMKK2-AMPKα signaling pathway was activated to suppress oxidative stress. Apart from its anti-oxidative capacity, FGF21 activated eNOS to dilate the aorta via CaMKK2/AMPKα activation. Our data suggest expanded potential uses of FGF21 for the treatment of vascular diseases in diabetes.

Для цитирования: Ying Lei, Li Na, He Zhengyue, Zeng Xueqin, Nan Yan, Chen Jiantong, Miao Peipei, Ying Yunyun, Lin Wei, Zhao Xinyu, Lu Lu, Chen Mengke, Cen Wei, Guo Tonglin, Li Xiaokun, Huang Zhifeng, Wang Yang. Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway.. Cell death & disease. 2019. DOI: 10.1038/s41419-019-1893-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.